ResMed Inc. Insider Trading

RMD

Last 12 months

Insiders sold $21.6M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Aug 2016.

Net open-market

−$21.6M

0 buys · 31 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 5

executives and directors

Last open-market buy

Aug 2016

Aug 17, 2016

Get an email when RMD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 23	Michael J Rider Global General Counsel	Sold10b5-1 plan	400	$255.00	102K	3.1%	Form 4
Oct 7	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$226.33	$1.13M	1.0%	Form 4
Sep 8	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$222.44	$1.11M	1.1%	Form 4
Sep 2	Peter C Farrell Director	Sold10b5-1 plan	970	$234.73	228K	1.8%	Form 4
Aug 7	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$205.69	$1.03M	1.1%	Form 4
Aug 5	Peter C Farrell Director	Sold10b5-1 plan	8,000	$225.00	$1.8M	13%	Form 4
Jul 7	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$218.55	$1.09M	1.1%	Form 4
Jun 8	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$193.96	968K	1.1%	Form 4
May 7	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$207.82	$1.04M	1.1%	Form 4
Apr 7	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$225.50	$1.13M	1.1%	Form 4
Apr 1	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	1,000	$224.31	224K	1.2%	Form 4
Apr 1	Peter C Farrell Director	Sold10b5-1 plan	2,000	$225.00	450K	3.2%	Form 4
Mar 9	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$251.03	$1.25M	1.1%	Form 4
Mar 4	Peter C Farrell Director	Sold10b5-1 plan	2,000	$260.22	520K	3.1%	Form 4
Mar 2	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	1,000	$254.30	254K	1.2%	Form 4
Feb 9	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$273.78	$1.37M	1.1%	Form 4
Feb 4	Peter C Farrell Director	Sold10b5-1 plan	2,000	$251.31	503K	3.0%	Form 4
Feb 4	Michael J Rider Global General Counsel	Sold10b5-1 plan	50	$260.00	13K	0.5%	Form 4
Feb 2	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	1,000	$257.03	257K	1.2%	Form 4
Jan 7	Peter C Farrell Director	Sold10b5-1 plan	2,000	$248.83	498K	2.9%	Form 4
Jan 7	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$248.46	$1.24M	1.1%	Form 4
Jan 2	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	1,000	$241.75	242K	1.1%	Form 4
Jan 2	Michael J Rider Global General Counsel	Sold10b5-1 plan	50	$241.75	12K	0.5%	Form 4
Dec 8, 2025	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	4,991	$251.41	$1.25M	1.1%	Form 4
Dec 3, 2025	Peter C Farrell Director	Sold10b5-1 plan	2,000	$251.47	503K	2.8%	Form 4
Dec 1, 2025	Michael J Rider Global General Counsel	Sold10b5-1 plan	50	$244.16	12K	0.5%	Form 4
Dec 1, 2025	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	1,000	$244.16	244K	1.1%	Form 4
Nov 25, 2025	Jan De Witte Director	Sold10b5-1 plan	2,055	$255.00	524K	33%	Form 4
Nov 12, 2025	Peter C Farrell Director	Sold10b5-1 plan	2,000	$252.05	504K	2.9%	Form 4
Nov 11, 2025	Jan De Witte Director	Sold10b5-1 plan	487	$250.25	122K	8.5%	Form 4
Nov 7, 2025	Michael J. Farrell Chairman and CEO	Sold10b5-1 plan	8,011	$249.75	$2M	1.7%	Form 4
Nov 3, 2025	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	3,000	$247.54	743K	3.4%	Form 4
Oct 7, 2025	Michael J. Farrell Chief Executive Officer	Sold10b5-1 plan	8,009	$282.85	$2.27M	1.7%	Form 4
Oct 1, 2025	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	3,000	$274.36	823K	3.3%	Form 4
Oct 1, 2025	Michael J Rider Global General Counsel	Sold10b5-1 plan	100	$274.36	27K	0.9%	Form 4
Sep 8, 2025	Michael J. Farrell Chief Executive Officer	Sold10b5-1 plan	8,009	$278.14	$2.23M	1.7%	Form 4
Sep 2, 2025	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	3,000	$270.77	812K	3.3%	Form 4
Aug 18, 2025	John Hernandez Director	SoldNo plan	2,575	$287.10	739K	39%	Form 4
Aug 7, 2025	Michael J. Farrell Chief Executive Officer	Sold10b5-1 plan	8,009	$279.48	$2.24M	1.7%	Form 4
Aug 1, 2025	Brett Sandercock Chief Financial Officer	Sold10b5-1 plan	3,000	$281.90	846K	3.5%	Form 4

Oct 2310b5-1 plan
Michael J Rider
Global General Counsel · sold 400 at $255.00
102K
3.1% of stake
Oct 710b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $226.33
$1.13M
1.0% of stake
Sep 810b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $222.44
$1.11M
1.1% of stake
Sep 210b5-1 plan
Peter C Farrell
Director · sold 970 at $234.73
228K
1.8% of stake
Aug 710b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $205.69
$1.03M
1.1% of stake
Aug 510b5-1 plan
Peter C Farrell
Director · sold 8,000 at $225.00
$1.8M
13% of stake
Jul 710b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $218.55
$1.09M
1.1% of stake
Jun 810b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $193.96
968K
1.1% of stake
May 710b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $207.82
$1.04M
1.1% of stake
Apr 710b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $225.50
$1.13M
1.1% of stake
Apr 110b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 1,000 at $224.31
224K
1.2% of stake
Apr 110b5-1 plan
Peter C Farrell
Director · sold 2,000 at $225.00
450K
3.2% of stake
Mar 910b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $251.03
$1.25M
1.1% of stake
Mar 410b5-1 plan
Peter C Farrell
Director · sold 2,000 at $260.22
520K
3.1% of stake
Mar 210b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 1,000 at $254.30
254K
1.2% of stake
Feb 910b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $273.78
$1.37M
1.1% of stake
Feb 410b5-1 plan
Peter C Farrell
Director · sold 2,000 at $251.31
503K
3.0% of stake
Feb 410b5-1 plan
Michael J Rider
Global General Counsel · sold 50 at $260.00
13K
0.5% of stake
Feb 210b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 1,000 at $257.03
257K
1.2% of stake
Jan 710b5-1 plan
Peter C Farrell
Director · sold 2,000 at $248.83
498K
2.9% of stake
Jan 710b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $248.46
$1.24M
1.1% of stake
Jan 210b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 1,000 at $241.75
242K
1.1% of stake
Jan 210b5-1 plan
Michael J Rider
Global General Counsel · sold 50 at $241.75
12K
0.5% of stake
Dec 8, 202510b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 4,991 at $251.41
$1.25M
1.1% of stake
Dec 3, 202510b5-1 plan
Peter C Farrell
Director · sold 2,000 at $251.47
503K
2.8% of stake
Dec 1, 202510b5-1 plan
Michael J Rider
Global General Counsel · sold 50 at $244.16
12K
0.5% of stake
Dec 1, 202510b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 1,000 at $244.16
244K
1.1% of stake
Nov 25, 202510b5-1 plan
Jan De Witte
Director · sold 2,055 at $255.00
524K
33% of stake
Nov 12, 202510b5-1 plan
Peter C Farrell
Director · sold 2,000 at $252.05
504K
2.9% of stake
Nov 11, 202510b5-1 plan
Jan De Witte
Director · sold 487 at $250.25
122K
8.5% of stake
Nov 7, 202510b5-1 plan
Michael J. Farrell
Chairman and CEO · sold 8,011 at $249.75
$2M
1.7% of stake
Nov 3, 202510b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 3,000 at $247.54
743K
3.4% of stake
Oct 7, 202510b5-1 plan
Michael J. Farrell
Chief Executive Officer · sold 8,009 at $282.85
$2.27M
1.7% of stake
Oct 1, 202510b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 3,000 at $274.36
823K
3.3% of stake
Oct 1, 202510b5-1 plan
Michael J Rider
Global General Counsel · sold 100 at $274.36
27K
0.9% of stake
Sep 8, 202510b5-1 plan
Michael J. Farrell
Chief Executive Officer · sold 8,009 at $278.14
$2.23M
1.7% of stake
Sep 2, 202510b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 3,000 at $270.77
812K
3.3% of stake
Aug 18, 2025No plan
John Hernandez
Director · sold 2,575 at $287.10
739K
39% of stake
Aug 7, 202510b5-1 plan
Michael J. Farrell
Chief Executive Officer · sold 8,009 at $279.48
$2.24M
1.7% of stake
Aug 1, 202510b5-1 plan
Brett Sandercock
Chief Financial Officer · sold 3,000 at $281.90
846K
3.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RMD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with RMD

CompareIntrinsic value

DXCMDexCom, Inc.

$88.47+6.63%85

WSTWest Pharmaceutical Services, Inc.

$408.78+0.44%46

SOLVSolventum Corporation

$89.35+5.42%38

GMEDGlobus Medical Inc.

$87.10+9.45%71

MMEDMiniMed Group, Inc.

$19.29+2.33%25

PODDInsulet Corporation

$165.02+6.56%75

TFXTeleflex Incorporated

$149.87+7.09%16

ICUIIcu Medical Inc.

$172.62+6.67%46

Held by ETFs

RMD is in 303 US ETFs. The largest of them, with RMD's weight in each:

Spot a number that looks wrong? Check it in RMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RMD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.